Pestalozzi advised Adragos Pharma in the Acquisition of Baccinex. The Pestalozzi team included: Christian Leuenberger, Raphael Widmer, Fabienne Schaub, Andrew D. Galantay, Michael Lips, Melanie von Rickenbach, Sarah Drukarch, Jonas Sigrist, Christian Roos, Seraina Würgler, and Larissa Rickenbacher. Learn more here: https://lnkd.in/eehudNPx #pestalozzilaw #dealsandcases
Pestalozzi Attorneys at Law’s Post
More Relevant Posts
-
Watch the latest interview with Magnus Corfitzen, CEO of Ascelia Pharma AB on Redeye AB. Magnus shared his insights on the timeline for the NDA submission of Orviglance, set for the middle of next year. He also highlighted how the ongoing Rights Issue will help securing an attractive commercial partnering agreement to maximize access to Orviglance for patients. Investors can read about our ongoing Rights Issue and how to participate on our website and in our recent press releases. www.ascelia.com #Rightsissue #update #interview
-
Growth marketing leader | Go-to-market strategy | Segmentation and targeting | Content strategy | Demand generation
Come meet our team this fall and learn how Pii can help you overcome challenges in your drug development journey.
Pii (Pharmaceutics International, Inc.)'s team is gearing up for two major conferences in New Jersey next month! September is going to be a very busy and exciting time for us! 🔷 Pharma ChemOutsourcing Conference 📍 Parsippany, NJ 📅 September 3-6 🔷 Contract Pharma Conference 📍 New Brunswick, NJ 📅 September 26-27 These events are set to be fantastic opportunities for networking with fellow industry experts and our team can’t wait to dive in and connect with everyone. Hope to see you there! #Pharma #DrugDevelopment #CDMO #Networking
-
-
Enosium Life Science announces three strategic acquisitions in France and the UK: Inbeeo, Vyoo Agency, and Epione group, aiming to become the European leader in Life Science consulting. 🎯 With its first three acquisitions, Enosium Life Science, supported by Otium, reaffirms its ambition to build a multi-specialist group dedicated to life sciences across the entire value chain of healthcare products, from clinical development to commercialization. ✅ According to Antoine Amer, CEO and Founder of Enosium Life Science: "We aim to be the partner of choice for pharmaceutical, biotech, and medtech companies by offering highly specialized scientific services across Europe and throughout the entire healthcare product value chain." 👇 Find the full press release below 👇 https://lnkd.in/e8q9EykR Antoine Bassel Amer, Founder and CEO of Enosium Life Science Herve Lilliu, President and Founder of Inbeeo Stephane Roze, President and Founder of Vyoo Catherine Auzimour, Pierre-Louis PROST, Groupe Epione, KPL, Alinéa Plus, Sirius François Durvye, General Director at Otium Capital Basile Paul-Petit, Partner at Otium Capital Gabriel MARTIN #HealthInnovation #Healthtech #Biotech #Medtech #Pharmaceuticals #FranceBiotech #LEEM
-
In this Pod with CEO Magnus Corfitzen and Deputy CEO Julie Waras Brogren you can hear more about what’s next for Orviglance and Ascelia Pharma AB in 2024. Key topics include the upcoming headline results for Orviglance phase 3 study by May 2024 and our recent financing. #asceliapharma #update
Ascelia Pharma AB - Pod with CEO Magnus Corfitzen and Deputy CEO Julie Waras Brogren on potential milestones in 2024. Watch here 👇 Disclaimer: HCA l receives payment from Ascelia Pharma AB for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 11:15 AM 05-03-2024.
-
Have you heard the news? Amsino recently closed on the acquisition of MedXL! MedXL is a Canadian based manufacturer specializing in drug delivery devices – particularly prefilled syringes. This acquisition supports Amsino’s reshoring strategy to expand our North American manufacturing. This strategy aims to drive supply chain resiliency through dual sourced manufacturing in addition to the geopolitical landscape of the market. Read our press release linked below for more on this exciting news!
AMSINO EXPANDS NORTH AMERICAN MANUFACTURING AND DOUBLES CAPACITY WITH THE ACQUISITION OF MEDXL INC.
prnewswire.com
-
Thoughts on this? >> Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical
Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down
endpts.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical
Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down
endpts.com
-
Always great to see you Tugba Sacli. Thank you for attending euroPLX 85 Dublin Berk Şen and Centurion Pharma. See you soon again. #europlx #raucon #businessdevelopment #business #development #event #sales #events #tips #tip #partnering #success #pro #networking #network #pharma #pharmaceutical #opportunities #businessopportunities #networkingevent #benchmark
We are proud to have represented Centurion Pharma at EuroPLX 85 in Dublin. Many thanks to RauCon Business Development for providing the opportunity for valuable new collaborations in our industry through this successful event, and to industry peers and our potential partners for the productive meetings. #centurion #raucon #europlx #europlx85 #dublin #pharma
-
-
Expanded Access to Medicines | Business Development | Strategic Partnerships | Deal Structuring | Patient Advocate
If you're attending the Expanded Access Programs World Congress next week in London, definitely find time to check out Ana Paula Tediosi's presentation, or catch her during the conference. Ana is a wealth of knowledge when it comes to end to end strategy for all types of access programs (among so many other things)! #earlyaccessprograms, #expandedaccess, #posttrialaccess, #compassionateuse, #clinicaltrials WEP Clinical
Our Head of Expanded Access Strategy Ana Paula Tediosi is looking forward to presenting at the 6th Expanded Access Progammes World Congress 2024 Europe, next week in London. In her presentation, Ana will be providing guidance on navigating asset transitions which involve an EAP. Asset transition is a common challenge for many pharmaceutical companies, and often EAP/CUP and NPP aspects are overlooked, which can create difficulties for the teams involved. If you will be at the event, make sure you check out Ana’s presentation on day 1 at 11.30am. #expandedaccess #compassionateuse #WithEveryPatient #TreatmentAccessSolutions
-
-
Beige Ltd is planning to sell approximately 2.90% of its stake in Mankind Pharma Ltd. Beige Ltd, an affiliate of private equity firm ChrysCapital, is planning to sell approximately 2.90% of its stake in drug firm Mankind Pharma Ltd through block deals. The shares are expected to be offered at a price range of ₹2,103-₹2,214. The deal is estimated to be valued at ₹2,460 crore. Currently, Beige Ltd holds a 2.99% stake in Mankind Pharma Ltd. Interestingly, the offer price for these block deals comes at a slight discount, ranging from 0-5% below the current market price (CMP). #stockmarket #Investmentstrategy #financialplanning #investmentgoals #financialfreedom #diversifyyourportfolio #InvestmentTips
-
